The global prevalence of nonalcoholic fatty liver disease (NAFLD) has dramatically
increased in parallel with the epidemic of obesity. Controversy has emerged around dietary …

Non‐alcoholic fatty liver disease (NAFLD) is one of the most common causes of hepatic
disorders. It represents a wide range of chronic liver diseases in patients with no history of …

Lifestyle represents the most relevant factor for non‐alcoholic fatty liver disease (NAFLD) as
the hepatic manifestation of the metabolic syndrome. Although a tremendous body of clinical …

Nonalcoholic liver disease (NAFLD) is the most common cause of liver diseases in Western
populations and is fast becoming the top reason for liver transplants. 1 Its rising prevalence …

Background Metabolic dysfunction-associated fatty liver disease (MAFLD) is recently
recognized as a condition featured with metabolic dysfunctions in liver. It has been …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and
has no approved treatment. The hepatic farnesoid X receptor (FXR) is one of the most …

Nonalcoholic fatty liver disease (NAFLD) is on the rise worldwide representing a public
health issue. Its coexistence with obesity and other metabolic alterations is highly frequent …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide. NAFLD
management is mainly focused on weight loss, but the optimal characteristics of the diet …

Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic
liver disease without pharmacological treatment yet. There is also a lack of specific dietary …

Nutrition and dietary interventions are a central component in the pathophysiology, but also
a cornerstone in the management of patients with non-alcoholic fatty liver disease (NAFLD) …